Inhibition of experimental HCC growth in mice by use of the kinase inhibitor DMAT

Sass, Gabriele and Klinger, Nina and Sirma, Hueseyin and Hashemolhosseini, Said and Hellerbrand, Claus and Neureiter, Daniel and Wege, Henning and Ocker, Matthias and Tiegs, Gisa (2011) Inhibition of experimental HCC growth in mice by use of the kinase inhibitor DMAT. INTERNATIONAL JOURNAL OF ONCOLOGY, 39 (2). pp. 433-442. ISSN 1019-6439,

Full text not available from this repository. (Request a copy)

Abstract

The multi-kinase-inhibitor Sorafenib has been shown to prolong survival of patients suffering from hepatocellular carcinoma (HCC). We investigated effects of the serine/threonine kinase inhibitor 2-Dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole (DMAT) on experimental HCC growth, and identified mechanisms and target kinases of DMAT. Our results show that DMAT application in vivo reduced tumor growth in a xenotransplant model by interference with tumor cell proliferation. Biochemical parameters and histology following DMAT administration revealed no alterations in liver tissue. Similar to Sorafenib, DMAT interfered with NF kappa B activation and Wnt-signaling. Of the kinases inhibited by DMAT at almost equimolar IC(50), CK2 and PIM-3 were found to be over-expressed or more active in hepatoma cells and human HCC tissue. Knockdown of PIM-3 or CK2 by shRNA revealed that both kinases are important for hepatoma cell proliferation and survival. In conclusion, DMAT reduces HCC growth by interference with NF kappa B- and Wnt-signaling. PIM-3 and CK2 seem to be important target kinases. Inhibition of these kinases by application of inhibitors, e.g., DMAT, might represent a promising therapeutic approach in future HCC therapy.

Item Type: Article
Uncontrolled Keywords: HEPATOCELLULAR-CARCINOMA DEVELOPMENT; BAD-MEDIATED APOPTOSIS; PROTEIN-KINASE; CELL-LINES; KAPPA-B; CK2 INHIBITORS; CANCER; PIM-3; WNT; PHOSPHORYLATION; targeted therapy; CK2; PIM-3; wnt; NF kappa B
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin I
Depositing User: Dr. Gernot Deinzer
Date Deposited: 05 Jun 2020 04:41
Last Modified: 05 Jun 2020 04:41
URI: https://pred.uni-regensburg.de/id/eprint/20502

Actions (login required)

View Item View Item